INBIOGEN CO., Ltd.(KR:101140)
â‚©4,685.00-20.00 (-0.43%)
KR:101140
INBIOGEN CO., Ltd. financials statements
â‚©4,685.00
At close:-20.00 (-0.43%)
Want to see KR:101140 full AI Analyst Report?
INBIOGEN CO., Ltd. (101140) Ratios
INBIOGEN CO., Ltd. Ratios
KR:101140's free cash flow for Q2 2026 was ₩-1.15B. For the 2026 fiscal year, KR:101140's free cash flow was increased by ₩0.00 and operating cash flow was ₩-1.15B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.86 | 4.38 | 5.48 | 0.47 | 0.41 |
| Quick Ratio | 2.84 | 4.33 | 5.06 | 0.43 | 0.39 |
| Cash Ratio | 0.48 | 2.70 | 2.88 | 0.26 | 0.30 |
| Solvency Ratio | 2.63 | 5.94 | 7.66 | -3.16 | 1.02 |
| Operating Cash Flow Ratio | -2.98 | -0.02 | -0.50 | -0.32 | -0.09 |
| Short-Term Operating Cash Flow Coverage | -11.11 | 0.00 | 0.00 | -12.32 | -0.61 |
| Net Current Asset Value | â‚© 2.97B | â‚© 6.39B | â‚© 8.96B | â‚© -20.37B | â‚© -64.55B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.01 | 0.00 | 0.01 | 0.05 |
| Debt-to-Equity Ratio | 0.01 | 0.01 | 0.00 | 0.02 | 0.08 |
| Debt-to-Capital Ratio | 0.01 | 0.01 | 0.00 | 0.02 | 0.07 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.01 | 1.02 | 1.02 | 1.36 | 1.54 |
| Debt Service Coverage Ratio | -6.86 | 335.55 | 50.91 | 13.50 | -1.55 |
| Interest Coverage Ratio | -55.23 | -118.66 | -23.47 | 11.93 | -2.01 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.02 | 0.05 |
| Interest Debt Per Share | 124.08 | 94.76 | 85.62 | 1507.11 | 5802.60 |
| Net Debt to EBITDA | -0.07 | -0.28 | -0.41 | -0.17 | 1.39 |
| Profitability Margins | |||||
| Gross Profit Margin | -9.12% | 9.37% | 20.45% | 22.47% | 18.69% |
| EBIT Margin | -68.81% | 229.71% | 194.22% | -1163.52% | 1096.23% |
| EBITDA Margin | -63.04% | 244.72% | 213.83% | 398.64% | -67.07% |
| Operating Profit Margin | -68.81% | -86.54% | -98.58% | 386.03% | -73.33% |
| Pretax Profit Margin | -22.53% | 228.98% | 310.40% | -1198.21% | 1059.69% |
| Net Profit Margin | 92.48% | 228.98% | 302.16% | -1049.54% | 898.07% |
| Continuous Operations Profit Margin | 92.48% | 228.98% | 310.40% | -1047.19% | 898.07% |
| Net Income Per EBT | -410.49% | 100.00% | 97.34% | 87.59% | 84.75% |
| EBT Per EBIT | 32.74% | -264.59% | -314.89% | -310.39% | -1445.11% |
| Return on Assets (ROA) | 3.64% | 9.91% | 12.46% | -84.40% | 34.29% |
| Return on Equity (ROE) | 3.69% | 10.09% | 12.68% | -114.63% | 52.87% |
| Return on Capital Employed (ROCE) | -2.74% | -3.79% | -4.12% | 41.75% | -3.91% |
| Return on Invested Capital (ROIC) | -2.73% | -3.79% | -4.27% | 36.15% | -3.12% |
| Return on Tangible Assets | 3.64% | 9.92% | 12.52% | -84.70% | 34.35% |
| Earnings Yield | 5.53% | 17.29% | 20.21% | -212.96% | 44.49% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.46 | 2.05 | 1.49 | 2.08 | 1.68 |
| Payables Turnover | 25.17 | 9.33 | 15.62 | 28.63 | 13.19 |
| Inventory Turnover | 229.57 | 57.47 | 5.66 | 5.77 | 5.75 |
| Fixed Asset Turnover | 0.00 | 5.94 | 2.41 | 3.09 | 2.40 |
| Asset Turnover | 0.04 | 0.04 | 0.04 | 0.08 | 0.04 |
| Working Capital Turnover Ratio | 1.19 | 0.85 | -1.27 | -0.35 | 0.96 |
| Cash Conversion Cycle | 236.36 | 144.93 | 285.67 | 226.34 | 252.85 |
| Days of Sales Outstanding | 249.28 | 177.72 | 244.60 | 175.84 | 217.06 |
| Days of Inventory Outstanding | 1.59 | 6.35 | 64.45 | 63.25 | 63.47 |
| Days of Payables Outstanding | 14.50 | 39.14 | 23.37 | 12.75 | 27.67 |
| Operating Cycle | 250.87 | 184.07 | 309.05 | 239.09 | 280.52 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -552.97 | -3.32 | -105.16 | -3172.99 | -2379.29 |
| Free Cash Flow Per Share | -557.20 | -11.76 | -138.29 | -3264.19 | -3187.62 |
| Dividend Paid and CapEx Coverage Ratio | -130.67 | -0.39 | -3.17 | -34.79 | -2.94 |
| Capital Expenditure Coverage Ratio | -130.67 | -0.39 | -3.17 | -34.79 | -2.94 |
| Operating Cash Flow Coverage Ratio | -4.76 | -0.04 | -1.77 | -6.48 | -0.53 |
| Operating Cash Flow to Sales Ratio | -0.88 | -0.00 | -0.17 | -1.01 | -0.67 |
| Free Cash Flow Yield | -5.31% | -0.13% | -1.48% | -21.06% | -4.48% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 18.09 | 5.78 | 4.95 | -0.47 | 2.25 |
| Price-to-Sales (P/S) Ratio | 16.73 | 13.25 | 14.95 | 4.93 | 20.18 |
| Price-to-Book (P/B) Ratio | 0.67 | 0.58 | 0.63 | 0.54 | 1.19 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -18.83 | -794.31 | -67.54 | -4.75 | -22.34 |
| Price-to-Operating Cash Flow Ratio | -18.97 | -2814.88 | -88.81 | -4.88 | -29.92 |
| Price-to-Earnings Growth (PEG) Ratio | -0.28 | -0.40 | -0.05 | 0.00 | -0.02 |
| Enterprise Value Multiple | -26.61 | 5.13 | 6.58 | 1.07 | -28.71 |
| Enterprise Value | 105.63B | 88.44B | 87.82B | 48.69B | 201.80B |
| EV to EBITDA | -26.61 | 5.13 | 6.58 | 1.07 | -28.71 |
| EV to Sales | 16.77 | 12.56 | 14.07 | 4.27 | 19.25 |
| EV to Free Cash Flow | -18.87 | -753.24 | -63.56 | -4.11 | -21.31 |
| EV to Operating Cash Flow | -19.02 | -2669.36 | -83.58 | -4.23 | -28.55 |
| Tangible Book Value Per Share | 15695.29 | 15988.56 | 14817.06 | 28655.64 | 59762.19 |
| Shareholders’ Equity Per Share | 15695.29 | 16007.67 | 14882.06 | 28796.56 | 59917.88 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.12 | 0.15 |
| Revenue Per Share | 626.92 | 705.16 | 624.65 | 3145.03 | 3527.57 |
| Net Income Per Share | 579.80 | 1614.66 | 1887.43 | -33008.46 | 31680.01 |
| Tax Burden | -4.10 | 1.00 | 0.97 | 0.88 | 0.85 |
| Interest Burden | 0.33 | 1.00 | 1.60 | 1.03 | 0.97 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.28 | 0.37 | 0.47 | 0.37 | 0.45 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 3.91 | -0.00 | -0.06 | 0.10 | -0.08 |
Currency in KRW

